| scholarly article | Q13442814 |
| P2093 | author name string | Jinsil Seong | |
| Seo Hee Choi | |||
| P2860 | cites work | Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis | Q80615703 |
| Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma | Q82744829 | ||
| Repeated proton beam therapy for hepatocellular carcinoma | Q82965589 | ||
| Stereotactic body radiation therapy in recurrent hepatocellular carcinoma | Q83462187 | ||
| Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma | Q83869651 | ||
| Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation | Q83892459 | ||
| Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes | Q84214482 | ||
| Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis | Q84480800 | ||
| Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma | Q85643473 | ||
| A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma | Q85748134 | ||
| Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study | Q86256843 | ||
| The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma | Q86972497 | ||
| Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization | Q87024975 | ||
| Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis | Q26738533 | ||
| 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma | Q28392783 | ||
| Proton beam therapy for aged patients with hepatocellular carcinoma. | Q33375353 | ||
| Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis | Q33388097 | ||
| Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis | Q33438161 | ||
| Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer | Q33682891 | ||
| The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities | Q33746887 | ||
| Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (≥10 cm) hepatocellular carcinomas: A clinical study | Q33932984 | ||
| Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results | Q34002010 | ||
| Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies? | Q34229597 | ||
| Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma | Q34384265 | ||
| Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma | Q34386046 | ||
| High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma | Q34508914 | ||
| Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis | Q34758500 | ||
| Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma | Q34977179 | ||
| A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors | Q35082965 | ||
| Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy | Q35158760 | ||
| Radiation-associated liver injury. | Q35297759 | ||
| Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium | Q35809482 | ||
| Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma | Q35858275 | ||
| Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma | Q36074220 | ||
| Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. | Q36129548 | ||
| Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. | Q36175991 | ||
| Partial volume tolerance of the liver to radiation. | Q36267553 | ||
| Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis | Q36482535 | ||
| Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinoma | Q36589471 | ||
| Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma | Q36914411 | ||
| Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma | Q37458034 | ||
| Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. | Q37655677 | ||
| Tolerance of normal tissue to therapeutic irradiation | Q37717558 | ||
| Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. | Q37735607 | ||
| Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis | Q38286582 | ||
| Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience | Q38339108 | ||
| Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis | Q38407186 | ||
| Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis | Q38548584 | ||
| NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017 | Q38801422 | ||
| Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas? | Q39931417 | ||
| Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis | Q40797064 | ||
| Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis | Q41761634 | ||
| Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity | Q42260214 | ||
| Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity | Q43168109 | ||
| High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial | Q43667610 | ||
| Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols | Q43720201 | ||
| Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma | Q43897398 | ||
| Analysis of radiation-induced liver disease using the Lyman NTCP model. | Q44048914 | ||
| A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma | Q44132600 | ||
| Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis | Q44238324 | ||
| Large primary liver cancer treated by chemoembolization combined with radiotherapy successfully | Q44442438 | ||
| Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma | Q44539612 | ||
| Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis | Q44543480 | ||
| Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes | Q44655064 | ||
| Proton beam therapy for large hepatocellular carcinoma. | Q44816996 | ||
| Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion | Q44822260 | ||
| Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | Q44835494 | ||
| Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients | Q44913990 | ||
| Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies | Q45055043 | ||
| A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. | Q45141892 | ||
| Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma | Q45866946 | ||
| Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis | Q46070017 | ||
| Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma | Q46264494 | ||
| Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis | Q46491963 | ||
| The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial | Q46876312 | ||
| Chemoembolization of hepatocellular carcinoma: results of a metaanalysis | Q47709592 | ||
| Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. | Q50547845 | ||
| Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. | Q50695738 | ||
| Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. | Q50774679 | ||
| Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. | Q50795926 | ||
| Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. | Q50862982 | ||
| Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. | Q50998284 | ||
| Stereotactic body radiotherapy for primary hepatocellular carcinoma. | Q51028901 | ||
| A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. | Q51756111 | ||
| Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. | Q51778319 | ||
| Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. | Q51817296 | ||
| Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. | Q52142739 | ||
| Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. | Q53168115 | ||
| Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis. | Q53207273 | ||
| Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy. | Q53275925 | ||
| Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolizat | Q53348245 | ||
| Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis. | Q53356745 | ||
| Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. | Q53489624 | ||
| Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. | Q53516826 | ||
| Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. | Q53528172 | ||
| Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis | Q57551638 | ||
| Incidence and clinical outcome of icteric type hepatocellular carcinoma | Q57982398 | ||
| Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization | Q57987901 | ||
| Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma | Q57987907 | ||
| Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis | Q59652147 | ||
| Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma | Q59677992 | ||
| Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma | Q59678030 | ||
| Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma | Q60442452 | ||
| Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma | Q70130773 | ||
| Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma | Q73679331 | ||
| Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma | Q73764961 | ||
| Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma | Q73789140 | ||
| Stereotactic radiotherapy of primary liver cancer and hepatic metastases | Q80282837 | ||
| Clinical Results of Carbon Ion Radiotherapy at NIRS | Q80358857 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P304 | page(s) | 114-134 | |
| P577 | publication date | 2018-02-14 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Strategic Application of Radiotherapy for Hepatocellular Carcinoma | |
| P478 | volume | 24 |
| Q90577615 | Delayed response to proton beam treatment of hepatocellular carcinoma |
| Q91763427 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation |
| Q90705574 | Knockdown of interferon-stimulated gene 15 affects the sensitivity of hepatocellular carcinoma cells to norcantharidin |
| Q58603829 | Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature |
Search more.